Drug development companies include Radius Health, Stoke Therapeutics, Yumanity Therapeutics, Iovance Biotherapeutics, Harrow Health and 520 other companies.
Stoke Therapeutics is a developer of antisense oligonucleotide medicines that target ribonucleic acid (RNA) splicing to enhance gene expression for the treatment of genetic diseases.
Yumanity Therapeutics (formerly known as Proteostasis Therapeutics) is a biopharmaceutical company developing therapeutics to treat diseases caused by an imbalance in the proteostasis network.
Iovance Biotherapeutics (formerly Lion Biotechnologies) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes.
Harrow Health (formerly Imprimis Pharmaceuticals) is a pharmaceutical company dedicated to delivering high quality and innovative medicines to physicians and patients at accessible prices.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company engaged in identifying, developing, and commercializing niche branded pharmaceutical products.
Melodiol Global Health (formerly known as Creso Pharma) is a company that develops cannabis and hemp-derived therapeutic, nutraceutical, animal, and cosmetic products.